It's called Trikafta, and people living with Cystic Fibrosis describe it as a true game-changer. It can treat symptoms at the source rather than manage them endlessly every day. It was approved in the United States in 2019 but only arrived in most Canadian provinces a few months ago. Why did it take so long? How does this drug work? And is the approval process it went through a precedent of better days to come for Canada's health care system?GUEST: Jeremie Saunders, host of Sickboy, living with Cystic Fibrosis  We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:Through email at hello@thebigstorypodcast.ca Or @thebigstoryfpn on Twitter